Reuters logo
BRIEF-ACADIA Pharma surges in premarket after Parkinson's drug trial results
November 27, 2012 / 1:10 PM / 5 years ago

BRIEF-ACADIA Pharma surges in premarket after Parkinson's drug trial results

NEW YORK, Nov 27 (Reuters) - ACADIA Pharmaceuticals Inc : * Acadia Pharma surges 145.7 percent to $5.65 in premarket after company said its antipsychotic drug for Parkinson’s disease succeeded in meeting the primary goal and key secondary goals of a pivotal late stage clinical trial

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below